PLEASANTON, CA, US – NeoTract, Inc., today welcomed the announcement by NICE that its UroLift® System (Prostatic Urethral Lift) to treat an enlarged prostate (benign prostatic hyperplasia) saves the National Health Service (NHS) up to £286 ($443) per patient as a day case, compared to the most commonly used surgical intervention. NICE acknowledged the UroLift System has unique benefits, including preservation of sexual function, improved quality of life, reduced recovery time and the ability to treat high risk patients. … Continue reading NICE Evaluation and Tariff Code Announcements to Increase UroLift® System Availability in UK NHS Patients with Enlarged Prostate